Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2191]
News [5868]
Articles [116]
Editorials [31]
Conferences [186]
elearning [22]
Additional treatment options impact first-line treatment of mRCC: No
Prof Stéphan Oudard - Hôpital Européen Georges Pompidou, Paris, France
Additional treatment options impact first-line treatment of mRCC: No ( Prof Stéphan Oudard - Hôpital Européen Georges Pompidou, Paris, France )
23 Sep 2014
Discussion: Additional treatment options impact first-line treatment of mRCC
Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán
Discussion: Additional treatment options impact first-line treatment of mRCC ( Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán )
23 Sep 2014
Additional treatment options impact first-line treatment of mRCC: Yes
Prof Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium
Additional treatment options impact first-line treatment of mRCC: Yes ( Prof Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium )
23 Sep 2014
From clinical trial to clinical practice: Evidence from the real world
Dr Ignacio Durán - Associate Director of Clinical Research at START Madrid...
From clinical trial to clinical practice: Evidence from the real world ( Dr Ignacio Durán - Associate Director of Clinical Research at START Madrid, Madrid, Spain )
23 Sep 2014
Navigating current treatment options for HER2-positive MBC: Patient journey 1
Dr Rupert Bartsch - Medical University of Vienna, Vienna, Austria
Navigating current treatment options for HER2-positive MBC: Patient journey 1 ( Dr Rupert Bartsch - Medical University of Vienna, Vienna, Austria )
18 Sep 2014
ecancermedicalscience editor's choice for September 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for September 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
18 Sep 2014
Benefits of investing in skin cancer prevention
Craig Sinclair - Cancer Council Victoria, Victoria, Australia
Benefits of investing in skin cancer prevention ( Craig Sinclair - Cancer Council Victoria, Victoria, Australia )
11 Sep 2014
Biomarker found to aid in screening of squamous cell carcinoma
Dr Khadija Aljefri - Royal Victorian Infirmary Newcastle, Newcastle, UK
Biomarker found to aid in screening of squamous cell carcinoma ( Dr Khadija Aljefri - Royal Victorian Infirmary Newcastle, Newcastle, UK )
11 Sep 2014
The importance of the World Congress on Cancers of the Skin
Prof John Hawk - President of the World Congress on Cancers of the Skin 2014
The importance of the World Congress on Cancers of the Skin ( Prof John Hawk - President of the World Congress on Cancers of the Skin 2014 )
11 Sep 2014
Advances in CLL: Expert panel Discussion
Prof Robin Foà ; Prof Clemens Wendtner; Dr Francesc Bosch; Prof Florence...
Advances in CLL: Expert panel Discussion ( Prof Robin Foà ; Prof Clemens Wendtner; Dr Francesc Bosch; Prof Florence Cymbalista )
11 Sep 2014
Thrombosis in adult patients with chronic ITP
Dr Howard Liebman - University of Southern California, Los Angeles, USA
Thrombosis in adult patients with chronic ITP ( Dr Howard Liebman - University of Southern California, Los Angeles, USA )
4 Sep 2014
New players and targets in tumour vasculature
Dr Ugo Cavallaro - European Institue of Oncology, Milan, Italy
New players and targets in tumour vasculature ( Dr Ugo Cavallaro - European Institue of Oncology, Milan, Italy )
27 Aug 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation